Tenet Healthcare (THC) Stock Forecast & Price Target

$158.23

+3.01 (+1.94%)

(As of 08/21/2024 ET)

Tenet Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 17 Analyst Ratings

Based on 17 Wall Street analysts who have issued ratings for Tenet Healthcare in the last 12 months, the stock has a consensus rating of "Buy." Out of the 17 analysts, 1 has given a hold rating, 14 have given a buy rating, and 2 have given a strong buy rating for THC.

Consensus Price Target

$152.69
-3.50% Downside

High Forecast	$197.00
Average Forecast	$152.69
Low Forecast	$85.00

According to the 17 analysts' twelve-month price targets for Tenet Healthcare, the average price target is $152.69. The highest price target for THC is $197.00, while the lowest price target for THC is $85.00. The average price target represents a forecasted downside of -3.50% from the current price of $158.23.

Type	Current Forecast 8/23/23 to 8/22/24	1 Month Ago 7/24/23 to 7/23/24	3 Months Ago 5/25/23 to 5/24/24	1 Year Ago 8/23/22 to 8/23/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	14 Buy rating(s)	15 Buy rating(s)	14 Buy rating(s)	13 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$152.69	$123.18	$113.19	$82.94
Forecasted Upside	-3.50% Downside	17.76% Upside	22.45% Upside	23.98% Upside

Get Tenet Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

Ad Behind the Markets

Secure this "AI Fuel" Stock Before the Billionaires Buy It All

According to the Washington Post, America is running out of a crucial component for AI. Without this "AI fuel," firms like NVIDIA would have to shut down their operations.

Click here for the ticker >>>

THC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

THC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tenet Healthcare Stock vs. The Competition

Type	Tenet Healthcare	Medical Companies	S&P 500
Consensus Rating Score	3.06	2.75	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	-3.50% Downside	5,586.23% Upside	8.74% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/19/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$168.00 ➝ $168.00	+8.41%
8/14/2024	UBS Group 4 of 5 stars		Boost Target	Buy ➝ Buy	$180.00 ➝ $197.00	+27.91%
7/30/2024	The Goldman Sachs Group 2 of 5 stars		Boost Target	Buy ➝ Buy	$156.00 ➝ $173.00	+13.09%
7/30/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$145.00 ➝ $175.00	+14.53%
7/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$156.00 ➝ $171.00	+11.11%
7/25/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$130.00 ➝ $175.00	+17.04%
Get the Latest News and Ratings for THC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenet Healthcare and its competitors with MarketBeat's FREE daily newsletter.
7/25/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$139.00 ➝ $171.00	+14.37%
7/25/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$155.00 ➝ $170.00	+13.71%
6/28/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$150.00 ➝ $155.00	+16.40%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$107.00 ➝ $140.00	+4.67%
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$153.00	+16.31%
5/1/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$109.00 ➝ $136.00	+16.51%
5/1/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$118.00 ➝ $130.00	+13.23%
5/1/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$95.00 ➝ $122.00	+8.64%
3/27/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Peer Perform ➝ Outperform	$122.00	+19.21%
11/14/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$95.00 ➝ $85.00	+45.40%
8/2/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$92.00 ➝ $98.00	+27.60%
12/6/2022	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$40.00 ➝ $45.00	+2.25%
10/25/2022	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$89.00 ➝ $55.00	+40.99%
10/21/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$79.00 ➝ $64.00	+71.77%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:02 AM ET.

THC Forecast - Frequently Asked Questions

What is Tenet Healthcare's forecast for 2024?: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Tenet Healthcare is $152.69, with a high forecast of $197.00 and a low forecast of $85.00.
Should I buy or sell Tenet Healthcare stock right now?: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last twelve months. There is currently 1 hold rating, 14 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" THC shares.
Does Tenet Healthcare's stock price have much upside?: According to analysts, Tenet Healthcare's stock has a predicted upside of 15.22% based on their 12-month stock forecasts.
Has Tenet Healthcare been upgraded by Wall Street analysts recently?: Over the previous 90 days, Tenet Healthcare's stock had 1 upgrade by analysts.
What analysts cover Tenet Healthcare?: Tenet Healthcare has been rated by research analysts at Baird R W, Barclays, Cantor Fitzgerald, Citigroup, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Raymond James, Robert W. Baird, The Goldman Sachs Group, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Tenet Healthcare more than its competitors?: Analysts like Tenet Healthcare more than other "medical" companies. The consensus rating for Tenet Healthcare is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how THC compares to other companies.